Mortality Signal With Fractional Flow-Guided Tx in Halted Trial

ACC Conference Reporter

AHA 2016 | NEW ORLEANS — An excess mortality risk found with fractional flow reserve (FFR) guidance for treatment of multivessel disease halted the FUTURE trial but may not have dampened enthusiasm for the alternative to angiography. Read More >>>

Keywords: AHA Annual Scientific Sessions, AHA16

< Back to Listings